Microbiome Times Partnering Forum: Meet Your Next Collaborator

Connect with decision-makers spanning the global microbial ecosystem to propel dealmaking and innovation

San Francisco, November 3-4, 2026

Meet Dealmakers from biotech, VCs, consumer care and pharma

Building on the remarkable success of the European Edition, the Microbiome Times Forum USA will debut in 2026, bringing together more than 50 leading experts and over 300 industry professionals for two full days of discussion, networking, and breakthroughs in microbial product innovation. Taking place November 3-4 in San Francisco, this inaugural US event will serve as a new cornerstone gathering for researchers, founders, investors, and industry leaders shaping the future of microbiome-driven solutions.

Organised by Microbiome Times Magazine, the industry’s leading trade journal, the US edition of the MT Partnering Forum will spotlight emerging trends, scientific advances, regulatory challenges, and commercial opportunities accelerating the development of next-generation microbial products.

Free to attend for start-ups, academic innovators, investors, and healthcare organizations, the Forum gives participants direct access to future collaborators, partners, and customers. Attendees can schedule more than 30 one-on-one meetings through our customized partnering platform—ensuring maximum value and meaningful connections throughout the event.

Partnering. Networking. Industry Insights.

“MTIG looks forward to supporting Microbiome Times Partnering Forum this year as well! Our members are committed to fostering dialogue with stakeholders in the microbiome space to accelerate collaboration and innovation, and believe this event will serve as a venue to do just that.”

Nik Kimes, Chairman at MTIG and CEO at Siolta Therapeutics

“The microbiome-based therapies sector has specific challenges like for any emerging field. Recent progress towards late-stage clinical trials is encouraging and we see signs of increased maturity. In this context, unity is strength. Microbiome Times' annual event is a unique opportunity to highlight key industry players and foster fruitful collaborations that can advance this critical field”

Hervé Affagard. President of EMIH and CEO of Maat Pharma